A South Korean conglomerate, is in discussions to buy the US biotech firm for more than $40 billion. Biogen approached Samsung about a prospective acquisition of more than $42 billion,…
Tag:
A South Korean conglomerate, is in discussions to buy the US biotech firm for more than $40 billion. Biogen approached Samsung about a prospective acquisition of more than $42 billion,…